GSK Biologicals receives warning about cGMP compliance issues at its Quebec facility.

Novartis' 13th Annual Malaria Expert Panel focused on access to quality anti-malarials across Africa.

Rentschler plans to build two stainless-steel bioreactors to target market supply.

Medicenna Therapeutics selects Kalon Biotherapeutics to manufacture a new brain cancer drug for children and adults.

Recipharm and CTC will offer packages for Phase I studies.

SGS introduces the Cobas 6000 Analyzer System for its France-based laboratory.

Jones Packaging introduces a new solid dose vial line in its Toronto facility.

According to the National Bioscience Report, the US bioscience industry is on course for continued growth.

Abbott will acquire a controlling interest in the Russian pharmaceutical manufacturer Veropharm.

NIH launched 3D Print Exchange, a public website promoting health and science applications of 3D printing.

Shire reports that AbbVie offer undervalued company.

Dr. Reddy's recalls blood pressure drug due to failed dissolution tests.

FDA cites cGMP violations for API manufacturing at a facility in Tianjin, China.

Big pharma employment dropped by 3% between 2003 and 2013, according to a new jobs report published by EP Vantage.

New services manage clinical or drug manufacturing data in the Verizon cloud or from data centers.

Arecor and the Center for Process Innovation (CPI) Biologics are working on a project to enhance the compatibility of biologics with their containers.

FDA inspection found cGMP violations in the Bangalore, India API manufacturing facility.

Hospira announces a voluntary nationwide recall due to particulates from a glass defect.

The National Institutes of Health and the National Science Foundation set up biomedical innovation and business program.

EDQM details the agency?s accomplishments in 2013.

FDA issues guidance on the use of social media in regards to prescription drugs.

ISPE Metrics Pilot Program is designed to demonstrate the feasibility and value of standard quality metrics.

Funding boosts life-sciences manufacturing in West Michigan.

FDA provides advice to supply-chain stakeholders on how to identify suspect drug products and how to notify the agency of those products.

Novartis facility becomes the first US site licensed by the FDA to produce cell-culture influenza vaccines.

Catalent and AAPS announce the five winners of its annual academic competition.

EMA has published a new guidance template for the qualified person’s declaration concerning GMP compliance of API manufacture. The QP declaration template provides the basis for demonstrating compliance of the API manufacture with GMP requirements and ensures that the manufacturer has sufficient knowledge on the supply chain.

The fabrication facility will supply modular construction to the US life-science market.